RETATRUTIDE 20mg

RETATRUTIDE 20mg

1 x 10ml Multi-Vial  2mg / 1ml

20mg Premixed Retatrutide

NOTE: Includes 1 pack of 10 insulin syringes.

How Retatrutide Works

Retatrutide uniquely binds to GLP-1, GIP, and glucagon receptors. By activating these receptors simultaneously, it amplifies weight loss, enhances insulin secretion, optimises glucose metabolism, and boosts thermogenic processes, significantly outperforming peptides that target fewer metabolic pathways.

• GLP-1 (Glucagon-Like Peptide-1): Enhances satiety, reduces appetite, and promotes insulin secretion, directly aiding in weight loss and blood glucose regulation.
• GIP (Glucose-Dependent Insulinotropic Polypeptide): Facilitates improved insulin sensitivity and secretion, crucial for diabetes management.
• Glucagon: Boosts energy metabolism, increasing calorie burning and helping to mobilise fat stores effectively.

Scientific Backing and Clinical Research

Extensive preclinical studies and emerging clinical trials highlight Retatrutide’s profound efficacy. Early clinical data indicate substantial weight reduction, marked improvements in glucose tolerance, and significant metabolic benefits, positioning Retatrutide as a promising peptide in current obesity and diabetes research fields.

Who Should Use Retatrutide?

Retatrutide is strictly intended for use by qualified scientific researchers, laboratory personnel, and healthcare professionals involved in metabolic research. It is essential to underscore that Retatrutide is a research chemical, not approved for human consumption outside controlled, ethically approved clinical trials and laboratory settings.

Storage:

• Storage: Retatrutide should be stored in a cool, dry environment away from direct sunlight.
• Temperature: Recommended storage temperature is between 2°C and 8°C.
• Shelf Life: Under appropriate storage conditions, Retatrutide maintains stability and potency for optimal research use.